Gene · 3736
Papers2,297
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,297
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel KCNA1 Variant in a Patient With Tremor and Autism Spectrum Disorder Causes Mixed LOF/GOF Defects of Kv1.1 Channels. | Ann Clin Transl Neurol | 2026 | 42768297 | PubTator, text mining | PubMed |
Targeted Sequencing and Haplotype Analysis of Voltage-Gated Potassium Channel Genes Reveal a Potential Association of KCNV2 Haplotypes with Antiseizure Medication Response in Turkish Patients with Epilepsy. | Pharmaceuticals (Basel) | 2026 | 42653690 | PubTator, text mining | PubMed |
| A patent perspective of RSK inhibitors to treat cancer (2020-present). | Expert Opin Ther Pat | 2026 | 42508020 | PubTator, text mining | PubMed |
| Postmortem cerebellar and brainstem alterations in episodic ataxia type 1 and 2: Expanding the clinicopathological spectrum. | Clin Neuropathol | 2026 | 42290287 | PubTator, text mining | PubMed |
| Paroxysmal kinesigenic dyskinesia: clinical report of 10 cases from three pedigrees with literature review. | Neurol Sci | 2026 | 42168455 | PubTator, text mining | PubMed |
| Diagnostic approach to episodic ataxia types 1 and 2: a proposed algorithm for limited resource-settings. | Front Neurol | 2026 | 42093925 | PubTator, text mining | PubMed |
| Potassium Channelopathies and Precision Medicine Approaches in Epilepsy: A Systematic Review of Personalized Treatment Strategies. | Curr Neuropharmacol | 2026 | 42003125 | PubTator, text mining | PubMed |
| Ferroptosis in Glioblastoma and Neuroblastoma: Molecular Mechanisms and Novel Therapeutic Strategies. | Curr Issues Mol Biol | 2026 | 41899419 | PubTator, text mining | PubMed |
| Molecular Basis of the Inhibition of Voltage-Gated Potassium Channel Kv1.1 by Chinese Tarantula Peptide Huwentoxin-XI. | Toxins (Basel) | 2026 | 41893546 | PubTator, text mining | PubMed |
| A conserved bioelectrical signature defines subventricular zone-derived human fetal neural stem cells and tracks their differentiation state. | Front Cell Dev Biol | 2026 | 41890905 | PubTator, text mining | PubMed |
| Protein Tyrosine Phosphatases in Schizophrenia: A Review of Pathophysiology and Emerging Evidence. | Cureus | 2026 | 41769547 | PubTator, text mining | PubMed |
| Episodic Ataxia Associated With Synaptosomal-Associated Protein 25 (SNAP25) Variant: Beyond Epilepsy and Developmental Delay. | Cureus | 2026 | 41769487 | PubTator, text mining | PubMed |
| Associations between political orientation and allyship: Evidence from potential allies and their LGBTQ+ close others. | Sci Rep | 2026 | 41766011 | PubTator, text mining | PubMed |
| A rare presentation of CASPR2-associated Morvan syndrome overlapping with GM1-positive AMSAN: a case report. | Front Immunol | 2026 | 41756294 | PubTator, text mining | PubMed |
| Neurodegeneration Biomarkers in Epilepsy: A Critical Review of Current Findings. | Life (Basel) | 2026 | 41752932 | PubTator, text mining | PubMed |
| Evolution of Engineered ADAR-Based RNA Editing Systems. | Int J Mol Sci | 2026 | 41751993 | PubTator, text mining | PubMed |
| The Axon as a Self-Modifying Computational System: Autonomous Inference, Adaptive Propagation, and AI-Enabled Mechanistic Insight. | Int J Mol Sci | 2026 | 41751965 | PubTator, text mining | PubMed |
| Phosphoenolpyruvate carboxykinase 2 as a prognostic biomarker: expression and clinical significance in Group 3 and Group 4 medulloblastoma. | J Neurooncol | 2026 | 41739275 | PubTator, text mining | PubMed |
| CASPR2 Autoimmune Antibodies Induce Neuronal Hyperactivity in Human Brain Organoids. | J Neurochem | 2026 | 41725505 | PubTator, text mining | PubMed |
| Genetic-Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies. | Epigenomes | 2026 | 41718408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3736/papers